Oncology

Metastatic Breast Cancer

Advertisement

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2026

conference reporter by Komal Jhaveri, MD, FACP, FASCO
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Metastatic Breast Cancer presented at the San Antonio Breast Cancer Symposium 2026.


VIEW THE TOPICS:

 

  • After CDK4/6 Inhibition: Which Biomarkers Should Guide the Next Treatment Choice for HR+/HER2- Metastatic Breast Cancer?
  • Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
  • PI3K Pathway Targeting and Implications for the Treatment of HR+/HER2- Metastatic Breast Cancer
  • Questioning Precision in Therapies Without Molecular Selection for HR+ Metastatic Breast Cancer

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.

 

San Antonio Breast Cancer Symposium 2026

December 8 – December 11, 2026

Henry B. Gonzalez Convention Center

San Antonio, TX

Link to Registration

Komal Jhaveri, MD, FACP, FASCO

Associate Attending Physician, Breast Medicine and Early Drug Development Services
Section Head, Endocrine Therapy Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY

Advertisement